查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008769

干细胞製造市场报告：按产品、应用、最终用户和地区划分，2026-2034年

Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2025年全球干细胞生产市场规模达152亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到268亿美元，2026年至2034年的复合年增长率为6.30%。推动市场成长的因素包括：干细胞研究投资的增加、慢性病盛行率的上升、生物技术的进步、产学合作、严格的监管以及人们对干细胞疗法的认识不断提高。

干细胞製造市场的发展趋势：

增加对干细胞研究和再生医学的投资

由于大量投资涌入干细胞研究和再生医学领域，全球干细胞製造市场正经历显着成长。各国政府和私营机构纷纷加大对这些领域的投入，并认识到它们具有革新医学的巨大潜力。这主要得益于干细胞疗法在治疗以往难以治癒的疾病（例如神经退化性疾病和脊髓损伤）方面展现出的巨大前景。例如，2023年8月发表在《新英格兰医学杂誌》上的一篇论文重点介绍了干细胞基因疗法在治疗镰状细胞疾病（SCD）方面的巨大潜力。这些投资正在支持前沿研究、先进製造技术的开发以及临床试验的扩展。例如，2021年9月，LifeCell International Pvt. Ltd.获得了来自OrbiMed Asia Partners IV的22.5亿卢比（约2720万美元）投资，使其能够进一步利用其技术专长和广泛的网络，拓展到生育治疗和细胞疗法等相关新领域。此外，2023 年 11 月，美国一家专门从事重组蛋白和必需试剂的公司 ACROBiosystems Inc. 推出了 GM 级 DLL4 蛋白，这可溶性的Delta 样配体 4 (DLL4)，对干细胞的发育和分化至关重要。

慢性病发生率上升以及对创新治疗方法的需求

推动全球干细胞製造市场发展的另一个关键因素是慢性病盛行率的激增。糖尿病、心臟病和自体免疫疾病等疾病的发生率不断上升，治疗方法。干细胞疗法具有透过再生受损组织和器官来治疗这些疾病的巨大潜力。例如，2021年3月，Vertex Pharmaceuticals公司获得美国食品药物管理局（FDA）授予的快速通道核准，其研发的VX-880是一种用于治疗第1简审类糖尿病的人类干细胞衍生疗法。此外，根据美国食品药物管理局（FDA）2022年12月发布的数据，美国有超过7,000种罕见疾病，影响超过3,000万人。慢性病的盛行率随着老龄化的增长而增加，干细胞製造技术被视为对抗这些疾病的强大武器。例如，根据世界卫生组织 (WHO) 2021 年 10 月的情况说明书，预计到 2030 年，全球 65 岁及以上人口数量将达到 14 亿，到 2050 年将翻一番，达到 22 亿。

生物技术和细胞培养技术的进步

生物技术和细胞培养技术的进步正在革新干细胞生产领域。这些进步对于提高干细胞生产的效率和扩充性至关重要。细胞培养技术的突破性进展，例如3D细胞培养系统和生物反应器，使得大规模培养高品质干细胞成为可能。此外，基因编辑技术的创新，例如CRISPR-Cas9，能够精确控制干细胞的特性，进一步扩大其治疗潜力。这些进步不仅简化了生产流程，还确保了干细胞疗法的安全性和质量，从而赢得了医疗专业人员和患者的信任。例如，2021年9月，专注于干细胞生产的美国生物技术公司Cellino宣布了一项利用其专有系统提高产量并降低生产成本的方法。该系统整合了人工智慧、机器学习、雷射以及其他硬体和软体。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球干细胞製造市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 消耗品
    • 主要部分
      • 培养基
      • 其他的
  • 装置
    • 主要部分
      • 生物反应器培养箱
      • 细胞分选仪
      • 其他的
  • 干细胞株
    • 主要部分
      • 造血干细胞（HSC）
      • 间质干细胞（MSCs）
      • 诱导性多功能干细胞（iPSCs）
      • 胚胎干细胞（ESCs）
      • 神经干细胞（NSCs）
      • 多功能成体祖细胞

第七章 市场区隔：依应用领域划分

  • 研究用途
    • 主要部分
      • 生命科学研究
      • 药物发现与开发
  • 临床应用
    • 主要部分
      • 异体干细胞疗法
      • 自体干细胞疗法
  • 细胞和组织库的应用

第八章 市场区隔：依最终用户划分

  • 製药和生物技术公司
  • 学术机构、研究机构、合约研究组织
  • 医院/外科中心
  • 细胞和组织库
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • AcceGen
    • Bio-Rad Laboratories, Inc.
    • Cellular Engineering Technologies, Inc
    • Corning Incorporated
    • Lonza Group AG
    • REPROCELL Inc
    • Sartorius AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6072

The global stem cell manufacturing market size reached USD 15.2 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.30% during 2026-2034 . Increasing investments in stem cell research, rising chronic disease prevalence, advancements in biotechnology, collaborations between academia and industry, stringent regulations, and expanding awareness of stem cell therapies are stimulating the market growth.

STEM CELL MANUFACTURING MARKET ANALYSIS:

  • Major Market Drivers: Growing venture capital investment in stem cell research, supported by favorable government initiatives are majorly driving the stem cell manufacturing market. This, in turn, reflects the increasing recognition of stem cell's potential in advancing healthcare and regenerative medicine.
  • Key Market Trends: Some of the key trends in the stem cell manufacturing market include rising expenditure on stem cell research and regenerative medicine, automation of processes, increasing collaborations among industry players, and rapid advancements in bioreactor technology.
  • Geographical Trends: North America is leading the stem cell manufacturing market due to several factors, including the presence of leading biotechnology and pharmaceutical companies, a supportive regulatory framework towards clinical trials and commercialization of stem cell manufacturing, robust research and development (R&D) infrastructure, and the rising demand for regenerative medicine therapies in the region.
  • Competitive Landscape: Some of the major market players in the stem cell manufacturing industry include AcceGen, Bio-Rad Laboratories, Inc., Cellular Engineering Technologies, Inc, Corning Incorporated, Lonza Group AG, REPROCELL Inc, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: Government initiatives to boost the biotechnology and biopharmaceutical industries represent a significant opportunity for the market. Initiatives, such as grants, tax incentives, and subsidies, aim to promote R&D, attract investments, adopt advanced technologies, and accelerate scientific discoveries and innovations in therapies and treatments. However, the market also faces a significant challenge like technical limitations associated with manufacturing scale-up, which will require companies specialized equipment and infrastructure to overcome.

STEM CELL MANUFACTURING MARKET TRENDS:

Increasing Investments in Stem Cell Research and Regenerative Medicine

The global stem cell manufacturing market is experiencing a significant upsurge due to the substantial investments pouring into stem cell research and regenerative medicine. Governments and private organizations are channeling resources toward these fields, recognizing their potential to revolutionize healthcare. This driver is fueled by the promising prospects of stem cell therapies in addressing previously untreatable conditions, such as neurodegenerative diseases and spinal cord injuries. For instance, an article published in the New England Journal of Medicine in August 2023 revealed the anticipated potential of stem cell gene therapy in treating Sickle Cell Disease (SCD). These investments support cutting-edge research, the development of advanced manufacturing techniques, and the expansion of clinical trials. For example, in September 2021, LifeCell International Pvt. Ltd received an investment of INR 225 crore (USD 27.2 million) from OrbiMed Asia Partners IV to further leverage its technological expertise and wide network to foray into adjacent new categories like fertility health and cell-based therapeutics. Moreover, in November 2023, ACROBiosystems Inc., a US-based company specializing in recombinant proteins and essential reagents, launched GM-grade DLL4 protein, a soluble form of Delta-like Ligand 4 (DLL4), crucial in stem cell development and differentiation.

Rising Prevalence of Chronic Diseases and the Demand for Innovative Treatments

Another vital driver propelling the global stem cell manufacturing market is the escalating prevalence of chronic diseases. Conditions like diabetes, heart disease, and autoimmune disorders are on the rise, necessitating novel and effective treatments. Stem cell therapies hold immense promise in addressing these ailments by regenerating damaged tissues and organs. For instance, in March 2021, Vertex Pharmaceuticals received FDA grant as a fast track designation to VX-880, a human stem-cell derived therapy for patients with Type-1 diabetes. Moreover, as per the December 2022 data provided by the US Food and Drug Administration (FDA), there are over 7,000 rare diseases that affect more than 30 million people in the United States. The prevalence of chronic diseases rises with age, and stem cell manufacturing exhibits promise in combating these conditions. For example, a World Health Organization factsheet from October 2021 projects that globally there will be 1.4 billion people over the age of 65 by 2030 and this number is expected to double at 2.2 billion by 2050.

Advancements in Biotechnology and Cell Culture Techniques

Advancements in biotechnology and cell culture techniques are revolutionizing the field of stem cell manufacturing. This driver is pivotal in enhancing the efficiency and scalability of stem cell production. Breakthroughs in cell culture technology, such as 3D cell culture systems and bioreactors, enable the cultivation of high-quality stem cells in larger quantities. Additionally, innovations in genetic editing techniques, like CRISPR-Cas9, offer precise control over stem cell characteristics, further expanding their therapeutic potential. These advancements not only streamline the manufacturing process but also ensure the safety and quality of stem cell-based therapies, instilling confidence among healthcare professionals and patients alike. For instance, in September 2021, Cellino, a US-based biotech company with specialization in stem cell manufacturing, presented how its system integrates AI, machine learning, and lasers, along with other hardware and software, to enhance yields and reduce production costs.

STEM CELL MANUFACTURING MARKET SEGMENTATION:

Breakup by Product:

  • Consumables
    • Culture Media
    • Others
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Others
  • Stem Cell Lines
    • Hematopoietic Stem Cells (HSC)
    • Mesenchymal Stem Cells (MSC)
    • Induced Pluripotent Stem Cells (iPSC)
    • Embryonic Stem Cells (ESC)
    • Neural Stem Cells (NSC)
    • Multipotent Adult Progenitor Stem Cells

Consumables dominate the market

The consumables segment within the stem cell manufacturing market is experiencing robust growth due to the increasing adoption of stem cell-based research and therapies, necessitating a constant supply of consumables, including cell culture media, reagents, and growth factors. As research in this field expands, so does the demand for these essential materials. Moreover, the growing number of stem cell clinical trials and applications in regenerative medicine fuels the consumption of consumables. Clinical research and therapy development require a consistent and reliable source of high-quality consumables to ensure the safety and efficacy of stem cell-based treatments. In line with this, technological advancements in the production of consumables are driving growth.

Breakup by Application:

  • Research Applications
    • Life Science Research
    • Drug Discovery and Development
  • Clinical Application
    • Allogenic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Research applications dominate the market

The growth of the research applications segment within the stem cell manufacturing market is underpinned by the relentless pursuit of scientific knowledge and breakthrough discoveries in stem cell biology. Stem cells serve as essential tools for investigating various biological processes, disease mechanisms, and potential therapeutic avenues. Researchers across diverse fields, including regenerative medicine, developmental biology, and drug development, rely on stem cells to advance their studies. Moreover, the increasing funding and grants allocated to stem cell research bolster this segment's growth. Governments, private institutions, and non-profit organizations recognize the transformative potential of stem cell research and provide financial support to drive innovation. Additionally, technological advancements in stem cell culture techniques, genetic editing, and cell characterization tools enhance the efficiency and accuracy of research applications. These advancements enable researchers to work with a broader range of stem cell types and manipulate them with precision, further expanding the scope of research possibilities. For instance, in May 2023, Sernova announced research collaboration with AstraZeneca to evaluate novel potential therapeutic cell applications.

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks

Pharmaceutical & biotechnology companies dominate the market

The growth of pharmaceutical and biotechnology companies is propelled by the continuous expansion of the global population and the aging demographic trends. With an aging population, the demand for healthcare services, medications, and innovative therapies rises, providing a substantial market for pharmaceutical and biotechnology companies to cater to. Moreover, the increasing prevalence of chronic diseases, including cardiovascular disorders, cancer, and diabetes, necessitates ongoing research and the development of new pharmaceutical solutions. These companies play a pivotal role in creating advanced drugs and therapies to combat these health challenges. Furthermore, advancements in biotechnology, including gene therapy, precision medicine, and biopharmaceuticals, are shaping the industry.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest stem cell manufacturing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American region is experiencing robust growth in the stem cell manufacturing market, propelled by the substantial government funding and private investments in stem cell research and regenerative medicine. These financial commitments support cutting-edge research, clinical trials, and the development of advanced manufacturing techniques. Moreover, the prevalence of chronic diseases, such as diabetes, heart disease, and neurodegenerative disorders, is on the rise in North America. Stem cell therapies offer innovative solutions to address these conditions, fueling demand for their production. In line with this, the region boasts a highly developed biotechnology sector, leading to significant advancements in cell culture techniques and bioprocessing technologies. This ensures efficient and scalable stem cell production, strengthening the industry's foothold in North America. Furthermore, regulatory frameworks in North America provide a conducive environment for stem cell research and clinical trials, fostering growth and innovation. Collaborative efforts between academic institutions and industry players, along with growing public awareness of the potential of stem cell-based treatments, are additional drivers.

Competitive Landscape:

The competitive landscape within the global stem cell manufacturing market is characterized by a dynamic interplay of numerous players, each vying to establish their prominence and contribute to the industry's growth. These entities span a spectrum of organizations, including research institutions, biotechnology companies, pharmaceutical giants, and contract manufacturing organizations. Their diverse backgrounds and resources contribute to a multifaceted ecosystem that fosters innovation and advancements in stem cell manufacturing. Key competitive strategies encompass research and development efforts to enhance manufacturing processes, scale up production, and improve the quality and safety of stem cell-based therapies. Additionally, partnerships and collaborations between these players are common, facilitating knowledge sharing and the development of cutting-edge technologies. For instance, in June 2021, Catalent, in a strategic move, acquired RheinCell Therapeutics Gmbh for an undisclosed amount to expand the creation of advanced cell treatments, thereby enhancing Catalent's capacity for large-scale production. Regulatory compliance and adherence to ethical standards are pivotal in maintaining credibility within the market. Moreover, market participants often engage in marketing and educational initiatives to increase awareness of stem cell therapies among healthcare professionals and the public, further expanding their reach.

The report provides a comprehensive analysis of the competitive landscape in the global stem cell manufacturing market with detailed profiles of all major companies, including:

  • AcceGen
  • Bio-Rad Laboratories, Inc.
  • Cellular Engineering Technologies, Inc
  • Corning Incorporated
  • Lonza Group AG
  • REPROCELL Inc
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global stem cell manufacturing market in 2025?

2. What is the expected growth rate of the global stem cell manufacturing market during 2026-2034?

3. What are the key factors driving the global stem cell manufacturing market?

4. What has been the impact of COVID-19 on the global stem cell manufacturing market?

5. What is the breakup of the global stem cell manufacturing market based on product?

6. What is the breakup of the global stem cell manufacturing market based on the application?

7. What is the breakup of the global stem cell manufacturing market based on the end user?

8. What are the key regions in the global stem cell manufacturing market?

9. Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Culture Media
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bioreactors and Incubators
      • 6.2.2.2 Cell Sorters
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Stem Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hematopoietic Stem Cells (HSC)
      • 6.3.2.2 Mesenchymal Stem Cells (MSC)
      • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
      • 6.3.2.4 Embryonic Stem Cells (ESC)
      • 6.3.2.5 Neural Stem Cells (NSC)
      • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Life Science Research
      • 7.1.2.2 Drug Discovery and Development
    • 7.1.3 Market Forecast
  • 7.2 Clinical Application
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Allogenic Stem Cell Therapy
      • 7.2.2.2 Autologous Stem Cell Therapy
    • 7.2.3 Market Forecast
  • 7.3 Cell and Tissue Banking Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical & Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cell and Tissue banks
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AcceGen
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cellular Engineering Technologies, Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Corning Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Lonza Group AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 REPROCELL Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sartorius AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Takara Bio Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
  • Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
  • Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
  • Table 7: Global: Stem Cell Manufacturing Market: Key Players